ZNF740 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.66566760384512E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.75990000023307E-07 |
Normal-vs-Stage2 |
1.845890E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
7.413300E-04 |
Stage1-vs-Stage2 |
9.236400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.119400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.185000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.15254505728535E-13 |
Normal-vs-AfricanAmerican |
1.562970E-01 |
Normal-vs-Asian |
1.348290E-02 |
Caucasian-vs-AfricanAmerican |
1.420110E-03 |
Caucasian-vs-Asian |
4.915200E-01 |
AfricanAmerican-vs-Asian |
1.024810E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.29869999701648E-08 |
Normal-vs-Female |
9.01619999771341E-08 |
Male-vs-Female |
2.300200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.008180E-04 |
Normal-vs-Extreme_Weight |
2.7725000000256E-06 |
Normal-vs-Obese |
1.153490E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.611600E-01 |
Normal_Weight-vs-Obese |
4.074200E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.010000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.243600E-02 |
Normal-vs-Age(41-60Yrs) |
1.187260E-04 |
Normal-vs-Age(61-80Yrs) |
9.18789999637681E-09 |
Normal-vs-Age(81-100Yrs) |
2.811800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.633200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.661700E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.531400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.970000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.011000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.075400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.899600E-01 |
Normal-vs-Grade 3 |
2.003400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.567400E-01 |
Grade 2-vs-Grade 4 |
3.899600E-01 |
Grade 3-vs-Grade 4 |
2.003400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.91710006045309E-11 |
Normal-vs-N1 |
4.676700E-03 |
N0-vs-N1 |
7.731400E-01 |
|
|